TLR7 Signaling Shapes and Maintains Antibody Diversity Upon Virus-Like Particle Immunization
暂无分享,去创建一个
M. Vogel | A. Oxenius | A. Yermanos | M. Bachmann | Mona O. Mohsen | L. Zha | Pascal S. Krenger | Xinyue Chang | Caroline C. Krueger | Jiami Han | S. Roongta | Pascal S Krenger
[1] M. Vogel,et al. A scalable and highly immunogenic virus‐like particle‐based vaccine against SARS‐CoV‐2 , 2021, Allergy.
[2] M. Vogel,et al. Low‐affinity but high‐avidity interactions may offer an explanation for IgE‐mediated allergen cross‐reactivity , 2021, Allergy.
[3] M. Vogel,et al. Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles , 2021, Vaccines.
[4] M. Vogel,et al. AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate , 2021, Vaccines.
[5] M. Vogel,et al. SARS-CoV-2 structural features may explain limited neutralizing-antibody responses , 2021, NPJ vaccines.
[6] K. Fitzgerald,et al. Toll-like Receptors and the Control of Immunity , 2020, Cell.
[7] M. Vogel,et al. Vaccination Against Amyloidogenic Aggregates in Pancreatic Islets Prevents Development of Type 2 Diabetes Mellitus , 2020, Vaccines.
[8] Qingyuan Du,et al. Candidate , 2012, Juan Perón.
[9] M. Bachmann,et al. Type of RNA Packed in VLPs Impacts IgG Class Switching—Implications for an Influenza Vaccine Design , 2019, Vaccines.
[10] M. Vogel,et al. Vaccination with nanoparticles combined with micro-adjuvants protects against cancer , 2019, Journal of Immunotherapy for Cancer.
[11] M. Vogel,et al. RNA and Toll-Like Receptor 7 License the Generation of Superior Secondary Plasma Cells at Multiple Levels in a B Cell Intrinsic Fashion , 2019, Front. Immunol..
[12] M. Vogel,et al. Immunogenicity and Immunodominance in Antibody Responses. , 2019, Current topics in microbiology and immunology.
[13] M. Vogel,et al. An unexpected protective role of low‐affinity allergen‐specific IgG through the inhibitory receptor Fc&ggr;RIIb , 2018, The Journal of allergy and clinical immunology.
[14] Fuping Zhang,et al. B Cell–Intrinsic MyD88 Signaling Promotes Initial Cell Proliferation and Differentiation To Enhance the Germinal Center Response to a Virus-like Particle , 2018, The Journal of Immunology.
[15] J. Novák,et al. Humoral response of mice infected with Toxocara canis following different infection schemes , 2017, Acta Parasitologica.
[16] R. Maul,et al. Co-Stimulation of BCR and Toll-Like Receptor 7 Increases Somatic Hypermutation, Memory B Cell Formation, and Secondary Antibody Response to Protein Antigen , 2017, Front. Immunol..
[17] M. Bachmann,et al. Major findings and recent advances in virus-like particle (VLP)-based vaccines. , 2017, Seminars in immunology.
[18] D. Harper,et al. HPV vaccines - A review of the first decade. , 2017, Gynecologic oncology.
[19] A. Oxenius,et al. Dissecting the Contribution of IgG Subclasses in Restricting Airway Infection with Legionella pneumophila , 2014, The Journal of Immunology.
[20] Jim Euchner. Design , 2014, Catalysis from A to Z.
[21] H. Grönlund,et al. Mammalian-derived respiratory allergens - implications for diagnosis and therapy of individuals allergic to furry animals. , 2014, Methods.
[22] M. Matloubian,et al. B Cell–Intrinsic TLR7 Signaling Is Required for Optimal B Cell Responses during Chronic Viral Infection , 2013, The Journal of Immunology.
[23] A. DeFranco,et al. Contribution of Toll‐like receptor signaling to germinal center antibody responses , 2012, Immunological reviews.
[24] A. Macpherson,et al. Age, microbiota, and T cells shape diverse individual IgA repertoires in the intestine , 2012, The Journal of experimental medicine.
[25] R. Coffman,et al. Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response. , 2011, Immunity.
[26] C. Loddenkemper,et al. Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. , 2010, Immunity.
[27] Martin F. Bachmann,et al. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns , 2010, Nature Reviews Immunology.
[28] T. Kündig,et al. Mechanisms of allergen-specific desensitization. , 2010, The Journal of allergy and clinical immunology.
[29] M. Bachmann,et al. Cutting Edge: IL-21 and TLR Signaling Regulate Germinal Center Responses in a B Cell-Intrinsic Manner , 2010, The Journal of Immunology.
[30] M. Bachmann,et al. Isolation of human monoclonal antibodies by mammalian cell display , 2008, Proceedings of the National Academy of Sciences.
[31] Stephen W. Martin,et al. Heterogeneous antibody repertoire of marginal zone B cells specific for virus-like particles. , 2007, Microbes and infection.
[32] A. Jegerlehner,et al. TLR9 Signaling in B Cells Determines Class Switch Recombination to IgG2a , 2007, The Journal of Immunology.
[33] J. Coutelier,et al. Increased Efficacy of the Immunoglobulin G2a Subclass in Antibody-Mediated Protection against Lactate Dehydrogenase-Elevating Virus-Induced Polioencephalomyelitis Revealed with Switch Mutants , 2002, Journal of Virology.
[34] Ruslan Medzhitov,et al. Toll-like receptors and innate immunity , 2001, Nature Reviews Immunology.
[35] P. Pumpens,et al. Mutilation of RNA phage Qβ virus‐like particles: from icosahedrons to rods , 2000, FEBS letters.
[36] P. Pumpens,et al. Recombinant RNA phage Q beta capsid particles synthesized and self-assembled in Escherichia coli. , 1993, Gene.
[37] A. Denman. Cellular and Molecular Immunology , 1992 .
[38] Asphalt Pavement Mixes,et al. DEVELOPMENT OF A , 2011 .